Deutsche Bank Ag\ Orgenesis Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.19 - $5.88 $48,939 - $68,678	-11,680 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$4.77 - $8.08 $5,480 - $9,283	-1,149 Reduced 8.96%	11,680 $66,000
Q4 2020 Feb 16, 2021	BUY	$4.4 - $5.63 $16,020 - $20,498	3,641 Added 39.63%	12,829 $58,000
Q3 2020 Nov 12, 2020	BUY	$4.75 - $5.99 $4,132 - $5,211	870 Added 10.46%	9,188 $46,000
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.84 $29,944 - $65,213	8,318 New	8,318 $51,000
Q4 2018 Feb 14, 2019	SELL	$3.88 - $7.46 $2,374 - $4,565	-612 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.3 - $8.66 $3,243 - $5,299	612 New	612 $3,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.